Samuel Lafayette Murphy - Net Worth and Insider Trading
Samuel Lafayette Murphy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Samuel Lafayette Murphy owns 1 companies in total, including Viracta Therapeutics Inc (VIRX) .
Click here to see the complete history of Samuel Lafayette Murphy’s form 4 insider trades.
Insider Ownership Summary of Samuel Lafayette Murphy
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
VIRX | Viracta Therapeutics Inc | 2021-02-24 | director |
Samuel Lafayette Murphy Trading Performance
Samuel Lafayette Murphy Ownership Network
Samuel Lafayette Murphy Owned Company Details
What does Viracta Therapeutics Inc do?
Who are the key executives at Viracta Therapeutics Inc?
Samuel Lafayette Murphy is the director of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Executive Officer Daniel R. Chevallard , director & President and CEO Mark Rothera , and Chief Medical Officer Darrel P. Cohen .
Viracta Therapeutics Inc (VIRX) Insider Trades Summary
Over the past 18 months, Samuel Lafayette Murphy made no insider transaction in Viracta Therapeutics Inc (VIRX). Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 14,272 shares made by Daniel R. Chevallard , and a net purchase of 100,000 shares made by Mark Rothera .
In summary, during the past 3 months, insiders sold 0 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,272 shares of Viracta Therapeutics Inc (VIRX) were sold and 100,000 shares were bought by its insiders, resulting in a net purchase of 85,728 shares.
Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viracta Therapeutics Inc Insider Transactions
Samuel Lafayette Murphy Mailing Address
Above is the net worth, insider trading, and ownership report for Samuel Lafayette Murphy. You might contact Samuel Lafayette Murphy via mailing address: C/o Viracta Therapeutics, Inc., 2533 South Coast Hwy., Ste. 210, Cardiff Ca 92007.